Max Robotics — Global Service Robot Directory + US Certification

About

Michael B. Atkins is a leading figure in cancer immunotherapy and radiation oncology, with a research focus that bridges genomic tools and treatment-related immune effects. His early work contributed foundational resources to structural genomics, notably through the development of a deep-coverage bacterial artificial chromosome (BAC) library for the honey bee (*Apis mellifera*), a project that generated over 36,000 clones and established critical infrastructure for comparative genomic studies. This work, published in 2002, remains a reference point in entomological genomics. More recently, Atkins has turned his attention to the intersection of radiation therapy and immune function in oncology. His 2024 study on late radiation-related lymphopenia (RRL) after prostate stereotactic body radiation therapy (SBRT) is a timely contribution, examining how hypofractionated pelvic irradiation impacts chronic lymphocyte depletion—a factor increasingly linked to treatment toxicity and cancer control outcomes. Though early in its citation history, this work signals a growing focus on optimizing radiotherapy to preserve immune competence. Atkins’ career reflects a shift from foundational genomic resource-building to clinically relevant investigations of immune modulation, demonstrating versatility and a commitment to advancing precision cancer care.